We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
LGVN

Price
1.35
Stock movement down
-0.02 (-1.46%)
Company name
Longeveron LLC
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
18.03M
Ent value
-469.72K
Price/Sales
9.73
Price/Book
0.70
Div yield
-
Div growth
-
Growth years
-
FCF payout
-55.70%
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-36.92%
3 year return
-77.34%
5 year return
-
10 year return
-
Last updated: 2025-04-11

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

LGVN does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales9.73
Price to Book0.70
EV to Sales-0.25

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count13.35M
EPS (TTM)-1.31
FCF per share (TTM)-1.14

Income statement

Loading...
Income statement data
Revenue (TTM)1.85M
Gross profit (TTM)864.00K
Operating income (TTM)-17.68M
Net income (TTM)-17.92M
EPS (TTM)-1.31
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)46.65%
Operating margin (TTM)-954.59%
Profit margin (TTM)-967.49%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash22.78M
Net receivables380.00K
Total current assets23.77M
Goodwill0.00
Intangible assets2.35M
Property, plant and equipment8.58M
Total assets29.91M
Accounts payable887.00K
Short/Current long term debt1.60M
Total current liabilities3.10M
Total liabilities4.28M
Shareholder's equity25.63M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-14.49M
Capital expenditures (TTM)1.04M
Free cash flow (TTM)-15.53M
Dividends paid (TTM)8.65M

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-69.92%
Return on Assets-59.91%
Return on Invested Capital-68.28%
Cash Return on Invested Capital-59.17%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open1.34
Daily high1.39
Daily low1.26
Daily Volume62K
All-time high423.00
1y analyst estimate8.88
Beta0.35
EPS (TTM)-1.31
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
LGVNS&P500
Current price drop from All-time high-99.68%-14.41%
Highest price drop-99.81%-56.47%
Date of highest drop11 Jun 20249 Mar 2009
Avg drop from high-80.87%-11.07%
Avg time to new high131 days12 days
Max time to new high847 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
LGVN (Longeveron LLC) company logo
Marketcap
18.03M
Marketcap category
Small-cap
Description
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors. It is conducting Phase 1, Phase 1/2, Phase 2a, and Phase 2b clinical trials in various indications, such as aging-related frailty, alzheimer's disease, and hypoplastic left heart syndrome. Longeveron Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
Employees
23
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...